Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | KDM5A | P29375 | 2/20 | 0.61 |
| ▸ | KDM3A | Q9Y4C1 | 2/20 | 0.61 |
| ▸ | ASPH | Q12797 | 2/20 | 0.61 |
| ▸ | KDM8 | Q8N371 | 2/20 | 0.61 |
| ▸ | KDM6B | O15054 | 1/20 | 0.61 |
| ▸ | TET3 | O43151 | 1/20 | 0.61 |
| ▸ | KDM4A | O75164 | 1/20 | 0.61 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | KDM5C | P41229 | 1/20 | 0.61 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.61 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.61 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.61 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.61 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.61 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.61 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.61 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30524416 | 1.00 | KDM4E (0.61) | KDM4EALDH1A1KDM5AKDM3AASPH | |
| Iodide SCHEMBL3551537 | 0.98 | KDM4E (0.59) | KDM4EALDH1A1KDM5AKDM3AASPH | |
| SCHEMBL5700151 | 0.81 | ALDH1A1 (0.50) | KDM4EALDH1A1KDM5AKDM3AASPH | |
| SCHEMBL19918058 | 0.81 | ADORA3 (0.45) | KDM4EALDH1A1KDM5AKDM3AASPH | |
| SCHEMBL7513922 | 0.79 | KMO (0.71) | KDM4EALDH1A1KDM5AKDM3AASPH | |
| SCHEMBL30800092 | 0.79 | KMO (0.71) | KDM4EALDH1A1KDM5AKDM3AASPH | |
| SCHEMBL5700578 | 0.79 | KMT2A (0.59) | KDM4EALDH1A1KDM5AKDM3AASPH | |
| SCHEMBL14897947 | 0.78 | KDM4D (0.50) | KDM4EALDH1A1KDM5AKDM3AASPH | |
| SCHEMBL2490793 | 0.76 | ALDH1A1 (0.50) | KDM4EALDH1A1KDM3AKDM6BMAPT | |
| SCHEMBL17596266 | 0.76 | P2RX7 (0.49) | KDM4EALDH1A1KDM5AKDM3AASPH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1709 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-12497636-B2 | Recombinant Saccharomyces cerevisiae cells for cannabinoid production | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-12-16 | — | — | US | claimed |
| US-12478615-B2 | Prolyl hydroxylase inhibitors and methods of use | AKEBIA THERAPEUTICS, INC. (US) | 2025-11-25 | — | — | US | claimed |
| CN-120040329-A | Ring-opening steroid derivative containing oxime ester, preparation method and application thereof | 常州工业职业技术学院 | 2025-05-27 | — | — | CN | claimed |
| US-20240358691-A1 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE | WARNER CHILCOTT COMPANY, LLC (PR) | 2024-10-31 | — | — | US | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-114907201-B | Green synthesis method for synthesizing 2-menaquinone | 嘉兴学院 | 2024-05-24 | — | — | CN | claimed |
| CN-114656461-B | Quinoline ring-containing 1,2, 4-oxadiazole substituted benzamide compound and synthetic method and application thereof | 浙江工业大学 | 2024-01-30 | — | — | CN | claimed |
| CN-114920736-B | Quinoline ring-containing 1,2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof | 浙江工业大学 | 2024-01-30 | — | — | CN | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| CN-1163619-C | Method and compositions for determining sequence of nucleic acid molecules | �Ѹ�������ѧ��˾ | 2004-08-25 | — | — | CN | claimed |
| CN-1515541-A | Method for detecting ligand pair combination by using non-fluorescent marker and its composite | ռ�˹ | 2004-07-28 | — | — | CN | claimed |
| US-20020015826-A1 | Zwitterionic iodonium compounds and methods of application | CLEMSON UNIVERSITY | 2002-02-07 | — | — | US | claimed |
| US-RE37303-E1 | Imidazole compounds and their therapeutic applications | INSTITUT NATIONAL DEL LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2001-07-31 | — | — | US | claimed |
| CN-1212021-A | Method and compositions for determining sequence of nucleic acid molecules | RAPIGENE INC (US) | 1999-03-24 | — | — | CN | claimed |
| CN-1212019-A | Methods and compositions for detecting ligand pair binding using non-fluorescent labels | RAPIGENE INC (US) | 1999-03-24 | — | — | CN | claimed |
| US-5808164-A | Process for producing aromatic sulfides | PHILLIPE PETROLEUM COMPANY (US) | 1998-09-15 | — | — | US | claimed |
| US-5708171-A | HISTAMINE H3-RECEPTOR ANTAGONIST | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 1998-01-13 | — | — | US | claimed |
| US-5618981-A | Process for producing aromatic sulfides | PHILLIPS PETROLEUM COMPANY (US) | 1997-04-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020015826-A1 | Zwitterionic iodonium compounds and methods of application | DGKI, DSTN, PCNA | KDM4E 2180/4885ALDH1A1 3578/4885KDM5A 1094/4885 |
| US-20240358691-A1 | PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE | HIF1AN, EGLN3, EGLN2 | KDM4E 503/4885ALDH1A1 735/4885KDM5A 442/4885 |
| US-12478615-B2 | Prolyl hydroxylase inhibitors and methods of use | HIF1AN, EGLN3, HIF1A | KDM4E 562/4885ALDH1A1 444/4885KDM5A 494/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | KDM4E 1567/4885ALDH1A1 1723/4885KDM5A 1358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.